Journal Home
Search for

Volume 21, Issue 8, Pages 551-554 (December 2009)


View previous. 4 of 24 View next.

Comparison of the two different auditory evoked potentials index monitors in propofol-fentanyl-nitrous oxide anesthesia

Tomoki Nishiyama, MD, PhD (Director)Corresponding Author Informationemail address

Received 16 November 2007; received in revised form 19 December 2008; accepted 22 December 2008. published online 26 October 2009.

Abstract 

Study Objective

To determine the difference in performance of two different auditory evoked potentials (AEP) monitors, the A-Line AEP (AAI) and the aepEX, and their indices, during general anesthesia.

Design

Prospective study.

Setting

Operating room at a private hospital.

Patients

40 ASA physical status I and II women, aged 30 to 70 years, scheduled for partial mastectomy.

Interventions

Anesthesia was induced with propofol and fentanyl, and a Laryngeal Mask Airway (LMA) was inserted. Anesthesia was maintained with propofol, fentanyl, and nitrous oxide.

Measurements and Main Results

The AAI or the aepEX was continuously monitored and their performance was compared at the start of monitoring, at LMA insertion, after disturbance by electric cautery, and during anesthesia. Eighteen of 20 patients had low enough impedance to extract good electroencephalogram signals at the first electrode application with the A-Line AEP, and 14 of 20 patients, with the aepEX. The time to return to good signals after signal disturbance by electric cautery was 14 ± 3 seconds (SD) with the AAI and 19 ± 4 seconds (SD) with the aepEX (P = 0.035). Both AAI and aepEX decreased after anesthesia induction, with significantly lower values seen in AAI than the aepEX.

Conclusions

The A-Line AEP (AAI) is better detects the response to painful stimuli and during recovering from noise of electric cautery than the aepEX. The aepEX shows higher values than the AAI during propofol-fentanyl-nitrous oxide anesthesia.

Department of Anesthesiology and Critical Care, Kamagaya General Hospital, 929-6, hatsutomi, Kamagaya, Chiba, 273-0121, Japan

Corresponding Author Information4-7-3-2015, Minami-senju, Arakawa-ku, Tokyo, 116-0003, Japan. Tel.: +81 3 3806 7598; fax: +81 3 3806 7598.

 This study was performed at Ofuna Chuo Hospital, Kamakura, Japan.

PII: S0952-8180(09)00262-1

doi:10.1016/j.jclinane.2008.12.024


View previous. 4 of 24 View next.